INFUSION PUMP COLLEAGUE TRIPLE CHANNEL. Anvisa Registry: 10068390320. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Baxter Hospitalar Ltda 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    940
  • 날짜
    2008-09-24
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    In July 2007 Baxter Healthcare Corporation identified an irregularity related to the saturation condition of the buffer memory of the Colleague Triple Channel infusion pumps, which may cause these devices to interrupt the infusion under certain circumstances. Such irregularities may occur in Triple Channel Colleague equipment using the version (s) of Vista Balance software, Master 5.46 and Slave 4.02. For further information, please refer to the Notice of Technovigilance n ° 888. According to a recent company announcement to UTVIG / ANVISA, the root cause of the problem has been identified and the defects of the software have already been solved by Baxter Healthcare Corporation.
  • 원인
    Possibility of saturation of the buffer memory of the equipment / warning about incorrect use of batteries.
  • 조치
    Baxter Hospitalar Ltda started on September 15, 2008 a field action with the objective of updating software and part of the hardware of the Colleague Triple Channel infusion pumps. The action applies to all these equipment already marketed in Brazil. For further details on product changes, refer to Appendix 01 - Customer Letter of this alert. In addition, the company has informed UTVIG / ANVISA that NP2-12 batteries not purchased directly from Baxter and / or batteries labeled "Not indicated for medical use" should not be used with Colleague equipment.

Device

Manufacturer

  • Source
    ANVSANVISA